| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-07 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |